Transvision 2007 - Chicago, June 23rd - 26th
Aubrey de Grey
The central goal of my work is to expedite the development of a true cure for human aging. In my view, the main obstacle to developing such technology is the position of biogerontology at the boundary between basic science and medicine: the fundamental knowledge necessary to develop truly effective anti-aging medicine mostly exists, but the goal-directed frame of mind that is best suited to turning research findings into tools is very different from the curiosity-driven ethos that generated those findings in the first place. As a scientist with a training in an engineering discipline (computer science), I am unusually well placed to bridge this gap. I attempt to do so in three main ways: I do basic biogerontology research, I identify and promote specific technological approaches to the reversal (not merely the prevention) of various aspects of aging, and I argue in a wide range of fora (extending well beyond biologists) for the adoption of a more proactive approach to extending the healthy human lifespan sooner rather than later.
